VP-16, vincristine and procarbazine with radiation therapy for treatment of malignant brain tumors
- 1 April 1990
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 8 (2) , 163-166
- https://doi.org/10.1007/bf00177840
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Does chemotherapy benefit the patient with a central nervous system glioma?1987
- Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.Journal of Clinical Oncology, 1987
- Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomasJournal of Neurosurgery, 1985
- Synergistic antitumor activity of vincristine and VP-16-213Cancer Chemotherapy and Pharmacology, 1984
- Etoposide (VP-16-213) in malignant brain tumors: a phase II study.Journal of Clinical Oncology, 1984
- Lack of potentiation of vincristine-induced neurotoxicity by VP-16–213American Journal of Clinical Oncology, 1983
- Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials.1980